[Colloidal bismuth subcitrate: several pharmacokinetic considerations and of clinical application].
Alcalde
M
M
Departamento de Gastroenterología y Hepatología, Hospital de La Princesa, Universidad Autónoma, Madrid.
Sánchez
P
P
Lancho
A
A
Rodríguez
S J
SJ
Pajares García
J M
JM
D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000191:economics / Q000493:pharmacokinetics / Q000494:pharmacology; D003362:Cost-Benefit Analysis; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D016481:Helicobacter Infections / Q000188:drug therapy; D016480:Helicobacter pylori; D006801:Humans; D009942:Organometallic Compounds / Q000737:chemistry / Q000191:economics / Q000493:pharmacokinetics / Q000494:pharmacology; D014018:Tissue Distribution
D000900:Anti-Bacterial Agents; D009942:Organometallic Compounds; C002791:bismuth tripotassium dicitrate
Subcitrato de bismuto coloidal (SBC): algunas consideraciones farmacocinéticas y de aplicación clínica.